Hizentra: The Appearance Is Out Of Specification In The Affected Lot.
Hizentra Recall Summary Hizentra, an intravenous immunoglobulin medication, is being recalled in Canada because one lot does not meet appearance specifications. The affected product was distributed across Canada.
- Product
- Hizentra
- Reason
- Product quality concern
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2026-05-29
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/ba42d65e-6100-450c-9295-91b8386f0ea0